Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer
2023 · Nature Medicine · 430 citations
https://doi.org/10.1038/s41591-022-02115-4
M
Masahito Kotaka
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
237
Papers
2.5K
Citations
25
h-index
49
i10-index
Masahito Kotaka is an academic researcher. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Cancer Treatment and Pharmacology & Gastric Cancer Management and Outcomes. The author has an h-index of 25, co-authored 202 publications.
ORCID: 0000-0001-5976-613XPapers by this author
worksPrognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial)
2021 · British Journal of Cancer · 94 citations
https://doi.org/10.1038/s41416-020-01222-8
Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial)
2015 · Cancer Chemotherapy and Pharmacology · 28 citations
https://doi.org/10.1007/s00280-015-2757-0
Safety data from the phase III Japanese ACHIEVE trial: part of an international, prospective, planned pooled analysis of six phase III trials comparing 3 versus 6 months of oxaliplatin-based adjuvant chemotherapy for stage III colon cancer
2018 · ESMO Open · 28 citations
https://doi.org/10.1136/esmoopen-2018-000354
Trifluridine/tipiracil plus bevacizumab as a first‐line treatment for elderly patients with metastatic colorectal cancer (KSCC1602): A multicenter phase II trial
2020 · Cancer Medicine · 27 citations
https://doi.org/10.1002/cam4.3618
Protocol of the QUATTRO-II study: a multicenter randomized phase II study comparing CAPOXIRI plus bevacizumab with FOLFOXIRI plus bevacizumab as a first-line treatment in patients with metastatic colorectal cancer
2020 · BMC Cancer · 19 citations
https://doi.org/10.1186/s12885-020-07186-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat